has been cited by the following articles in journals that are participating in CrossRef's forward linking service: |
||
| Fetal hemoglobin in sickle cell anemia: Bayesian modeling of genetic associations Paola Sebastiani, Ling Wang, Vikki G. Nolan, Efthymia Melista, Qianli Ma, Clinton T. Baldwin, and Martin H. Steinberg American Journal of Hematology (2008) 83: 189 Link to Article |
||
| Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia Chutima Kumkhaek, James G. Taylor, Jianqiong Zhu, Carolyn Hoppe, Gregory J. Kato, and Griffin P. Rodgers British Journal of Haematology (2008) 141: 254 Link to Article |
||
| High expression of the cGMP-specific phosphodiesterase, PDE9A, in sickle cell disease (SCD) and the effects of its inhibition
in erythroid cells and SCD neutrophils Camila Bononi Almeida, Fabiola Traina, Carolina Lanaro, Andreia A. Canalli, Sara T. O. Saad, Fernando F. Costa, and Nicola Conran British Journal of Haematology (2008) 142: 836 Link to Article |
||
| IDENTIFICATION OF DIFFERENTIALLY EXPRESSED GENES INDUCED BY HYDROXYUREA IN RETICULOCYTES FROM SICKLE CELL ANAEMIA PATIENTS LS Moreira, TG de Andrade, DM Albuquerque, AF Cunha, A Fattori, STO Saad, and FF Costa Clinical and Experimental Pharmacology and Physiology (2008) 35: 651 Link to Article |
||
| Anemia and splenomegaly in cGKI-deficient mice M. Foller, S. Feil, K. Ghoreschi, S. Koka, A. Gerling, M. Thunemann, F. Hofmann, B. Schuler, J. Vogel, and B. Pichler Proceedings of the National Academy of Sciences (2008) 105: 6771 Link to Article |
||
| Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine's ability to induce
human fetal hemoglobin R. Mabaera, M. R. Greene, C. A. Richardson, S. J. Conine, C. D. Kozul, and C. H. Lowrey Blood (2007) 111: 411 Link to Article |
||
| Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells V. P. Cokic, S. A. Andric, S. S. Stojilkovic, C. T. Noguchi, and A. N. Schechter Blood (2007) 111: 1117 Link to Article |
||
| Expression of the ?-globin gene is sustained by the cAMP-dependent pathway in ?-thalassaemia Lakiea Bailey, Yuichi Kuroyanagi, Carla F. Franco-Penteado, Nicola Conran, Fernando F. Costa, Sabrina Ausenda, Maria D. Cappellini, and Tohru Ikuta British Journal of Haematology (2007) 138: 382 Link to Article |
||
| Gene expression profiles of erythroid precursors characterise several mechanisms of the action of hydroxycarbamide in sickle
cell anaemia Flávia Chagas Costa, Anderson Ferreira da Cunha, André Fattori, Tarcísio de Sousa Peres, Gustavo Gilson Lacerda Costa, Tiago Ferraz Machado, Dulcinéia Martins de Albuquerque, Sheley Gambero, Carolina Lanaro, and Sara T. Olala Saad British Journal of Haematology (2007) 136: 333 Link to Article |
||
| Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea Q Ma, D F Wyszynski, J J Farrell, A Kutlar, L A Farrer, C T Baldwin, and M H Steinberg The Pharmacogenomics Journal (2007) 7: 386 Link to Article |
||
| Modifier genes and sickle cell anemia Martin H Steinberg and Adeboye H Adewoye Current Opinion in Hematology (2006) 13: 131???136 Link to Article |
||
| Understanding mechanisms of γ-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction Betty S. Pace and Sima Zein Developmental Dynamics (2006) 235: 1727 Link to Article |
||
| Predicting clinical severity in sickle cell anaemia M. H. Steinberg British Journal of Haematology (2005) 129: 465 Link to Article |
||
| Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy Efemwonkiekie W. Iyamu, Renee Cecil, Leslie Parkin, Gerald Woods, Kwaku Ohene-Frempong, and Toshio Asakura British Journal of Haematology (2005) 131: 389 Link to Article |
||
| Increased soluble guanylate cyclase activity in the red blood cells of sickle cell patients Nicola Conran, Camila Oresco-Santos, Heloisa C. Acosta, Andre Fattori, Sara T. O. Saad, and Fernando F. Costa British Journal of Haematology (2004) 124: 547 Link to Article |
||
| Pathophysiological-Based Approaches to Treatment of Sickle Cell Disease Martin H. Steinberg and Carlo Brugnara Annual Review of Medicine (2003) 54: 89 Link to Article |
||
Christopher Reiter and Mark Gladwin Current Opinion in Hematology (2003) 10: 99 Link to Article |
||
| Drug therapy for sickle cell disease Efemwonkiekie W Iyamu and Toshio Asakura Expert Opinion on Therapeutic Patents (2003) 13: 807 Link to Article |
||
| Hydroxyurea induces fetal hemoglobin by the nitric oxide–dependent activation of soluble guanylyl cyclase Vladan P. Cokic, Reginald D. Smith, Bojana B. Beleslin-Cokic, Joyce M. Njoroge, Jeffery L. Miller, Mark T. Gladwin, and Alan N. Schechter Journal of Clinical Investigation (2003) 111: 231 Link to Article |
||
| A role for nitric oxide in hydroxyurea-mediated fetal hemoglobin induction S. Bruce King Journal of Clinical Investigation (2003) 111: 171 Link to Article |
||
| Age-related alterations in soluble guanylyl cyclase and cGMP pathway in spontaneously hypertensive rats Joseph Fomusi Ndisang and Rui Wang Journal of Hypertension (2003) 21: 1117 Link to Article |
||
Claudia Morris, Elliott Vichinsky, Jane van Warmerdam, Lorenzo Machado, Diane Kepka-Lenhart, , Morris, and Frans Kuypers Journal of Pediatric Hematology/Oncology (2003) 25: 629 Link to Article |
||
| Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease Mark T. Gladwin, James H. Shelhamer, Frederick P. Ognibene, Margaret E. Pease-Fye, James S. Nichols, Beth Link, Daksesh B. Patel, Marcin A. Jankowski, Lewis K. Pannell, and Alan N. Schechter British Journal of Haematology (2002) 116: 436 Link to Article |
||
| Nitric oxide and cyclic GMP levels in sickle cell patients receiving hydroxyurea Masoud Nahavandi, Fatemeh Tavakkoli, Melville Q. Wyche, Elliott Perlin, William P. Winter, and Oswaldo Castro British Journal of Haematology (2002) 119: 855 Link to Article |
||
Jeffery Miller Current Opinion in Hematology (2002) 9: 87 Link to Article |
||
| Developing treatment for sickle cell disease Carlo Brugnara and Martin H Steinberg Expert Opinion on Investigational Drugs (2002) 11: 645 Link to Article |
||